Technologies

Our patented modifications of the Sanger ‘Gold Standard’ sequencing method allow Syndromic Testing for the first time, whereby all the most prevalent pathogens causing a particular type of clinical presentation (e.g., diarrhea, meningitis, pneumonia etc.) are tested for simultaneously in one panel (multiplexing). The Company has a portfolio of unencumbered international patents that enable Best-in-Class accuracy, validation, and cost-effectiveness with multiple results per test panel, thereby responding to unfilled clinical need.

 

The process:

 Example of a test panel for sexually transmitted disease 

 

Test panels for clinical use